Adam J. Lamble

Also affiliated with University of Washington, Fred Hutch Cancer Center, Seattle Children's Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma”.

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Blood(2025)10.1182/blood.2024026655

N/A

0.505DataRank · unranked

28 citations

Alexander W. Rankin, Chloe Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova +76 more

Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.134692

N/A

0.292DataRank · unranked

6 citations

Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani +38 more

Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012436

N/A

0.244DataRank · unranked

4 citations

Flavia Gava, Yannis K. Valtis, Toshihisa Satta, Surabhi B Vora, Joseph M. Rocco +9 more

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Blood Advances(2022)10.1182/bloodadvances.2022007423

N/A

0DataRank · unranked

142 citations

Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg +24 more

Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.022

N/A

0DataRank · unranked

30 citations

Lena E. Winestone, Erin Sullivan, Qian Wu, Adam J. Lamble, Mark C. Walters +10 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.08.030

N/A

0DataRank · unranked

16 citations

Amy Moskop, Michael A. Pulsipher, Shannon L. Maude, Corinne Summers, Colleen Annesley +5 more

INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.10.005

N/A

0DataRank · unranked

10 citations

Deepa Bhojwani, Sara Ghorashian, Lori Muffly, Allison Barz Leahy, Karen Chao +7 more

CREBBP Alterations are Associated with A Poor Prognosis in de novo AML

Blood(2023)10.1182/blood.2022017545

N/A

0DataRank · unranked

14 citations

Kohei Hagiwara, Robert B. Gerbing, Jenny L. Smith, Pandurang Kolekar, Rhonda E. Ries +5 more

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1916206117

N/A

0DataRank · unranked

105 citations

Yoko Kosaka, Ted Laderas, Allie Maffit, Andy Kaempf, Lauren Brady +17 more

Pediatric oncologist referral practices for CAR T-cell therapy: A mixed methods study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10026

N/A

0DataRank · unranked

1 citations

Devan M. Duenas, Jenna Voutsinas, Vicky Wu, Adam J. Lamble, Benjamin S. Wilfond +4 more

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

Blood Advances(2024)10.1182/bloodadvances.2024013243

N/A

0DataRank · unranked

29 citations

Liora M. Schultz, Khanh Nguyen, Emily M. Hsieh, Kevin O. McNerney, Rayne H. Rouce +5 more

CRLF2 -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009499

N/A

0DataRank · unranked

8 citations

Samantha Scanlon, Hao‐Wei Wang, Constance M. Yuan, Alyssa Doverte, Jake Wellek +17 more

How I treat postimmunotherapy relapsed B-ALL

Blood(2024)10.1182/blood.2024024517

N/A

0DataRank · unranked

12 citations

Alexandra E. Kovach, Nirali N. Shah, Adam J. Lamble

Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae063

N/A

0DataRank · unranked

2 citations

Devan M. Duenas, Jenna Voutsinas, Qian Wu, Adam J. Lamble, Elizabeth Gruber +5 more

Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement

HemaSphere(2025)10.1002/hem3.70247

N/A

0DataRank · unranked

6 citations

Sandra D. Bohling, Kara L. Davis, Aimee C. Talleur, Kevin O. McNerney, Swati Naik +12 more

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

Blood Advances(2025)10.1182/bloodadvances.2025017011

N/A

0DataRank · unranked

7 citations

Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli, Anand Bhagwat, Challice L. Bonifant +30 more

Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.07.009

N/A

0DataRank · unranked

2 citations

Elad Jacoby, Adam J. Lamble, Shannon L. Maude, Kevin O. McNerney, Amy Moskop +4 more

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.21.01405

N/A

0DataRank · unranked

206 citations

Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates +23 more

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Nature Communications(2021)10.1038/s41467-021-21588-4

N/A

0DataRank · unranked

180 citations

Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani +38 more

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Blood(2021)10.1182/blood.2020009652

N/A

0DataRank · unranked

122 citations

Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken +13 more